Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1037120200380030345
The World Journal of Men¡Çs Health
2020 Volume.38 No. 3 p.345 ~ p.352
Molecular and Histologic Evidence of Novel Erectile Dysfunction Rat Model as an Aging Atherosclerosis Model: A Preliminary Study
Kim Jae-Heon

Shim Ji-Sung
Kim Jong-Wook
Doo Seung-Whan
Bae Jae-Hyun
Lee Ju-Han
Song Yun-Seob
Kim Je-Jong
Moon Du-Geon
Abstract
Purpose: To validate a novel arteriogenic erectile dysfunction (ED) model with atherosclerosis (AS) based on molecular and histologic evidence induced by chronic pelvic ischemia (CPI) and determine effect of phosphodiesterase-5 inhibitor treatment.

Materials and Methods: Twenty 16-week-old male Sprague?Dawley rats were divided into three experimental groups (Group I, untreated sham-operated rats with regular diet; Group II, CPI with cholesterol diet; Group III, CPI model with cholesterol diet and mirodenafil). Erectile function was accessed using maximum intracavernous pressure (ICP) and ICP/mean arterial pressure (MAP). Molecular changes were examined by western blot analysis using hypoxia inducible factor 1-alpha (HIF-1¥á), endothelial nitric oxide synthase (eNOS), and transforming growth factor beta-1 (TGF-¥â1) antibodies. Collagen change was evaluated by Masson's trichrome staining.

Results: In vivo measurements of ICP and ICP/MAP in Group II were significantly lower than those in Group I (p<0.01). Smooth muscle/collagen ratio in Group II was significantly lower than that in Group I (p<0.05). After treatment with mirodenafil for four weeks, Group III showed significantly higher levels of ICP and ICP/MAP than Group II (p<0.05). Western blot analysis showed that HIF-1¥á and TGF-¥â1 levels were significantly higher in Group II whereas eNOS levels were significantly lower in Group II than those in Group I or III.

Conclusions: A novel arteriogenic ED with AS model is successfully induced by CPI and validated based on molecular and histologic evidences.
KEYWORD
Atherosclerosis, Erectile dysfunction, Phosphodiesterase 5 Inhibitors, Vasculogenic impotence
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø